| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/03/2002 | EP1218049A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 07/03/2002 | EP1218033A2 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 07/03/2002 | EP1218026A2 Method to enhance healing of sternum after sternotomy |
| 07/03/2002 | EP1218023A2 Method for calming human beings using personal care compositions |
| 07/03/2002 | EP1218016A1 Composition and method for producing lubricating, germicide foam |
| 07/03/2002 | EP1218013A2 Phospholipid prodrugs of anti-proliferative drugs |
| 07/03/2002 | EP1218009A1 Quetiapine granules |
| 07/03/2002 | EP1218007A1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 07/03/2002 | EP1218001A1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 07/03/2002 | EP1217997A1 A process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
| 07/03/2002 | EP1217993A2 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 07/03/2002 | EP1217992A1 Coated solid dosage forms |
| 07/03/2002 | EP1217991A2 Emulsion-based processes for making microparticles |
| 07/03/2002 | EP1217990A1 Cationic dosper virosomes |
| 07/03/2002 | EP1217989A1 Liposome-entrapped dna oral vaccines |
| 07/03/2002 | EP1217988A1 Proteinic drug delivery system using membrane mimetics |
| 07/03/2002 | EP1217975A1 Using quaternary ammonium salts for transdermal drug delivery |
| 07/03/2002 | EP1146860A4 Polymeric delivery agents and delivery agent compounds |
| 07/03/2002 | EP1131062A4 Injectable propofol formulations |
| 07/03/2002 | EP1109536B1 New solid dose form of nanoparticulate naproxen |
| 07/03/2002 | EP1059920B1 Use of alkyl hydrogen fumarates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis |
| 07/03/2002 | EP0971729B1 Therapeutic powder formulation for pulmonary administration, containing crystalline insulin |
| 07/03/2002 | EP0942738B1 Polyethylene glycol esters of polyunsaturated fatty acids |
| 07/03/2002 | EP0934353B1 Method for preparation of polymer microparticles free of organic solvent traces |
| 07/03/2002 | EP0891180B1 Process for encapsulation of caplets in a capsule |
| 07/03/2002 | EP0820279B1 Metered dose inhaler for albuterol |
| 07/03/2002 | EP0813423B1 Composition to inhibit osteolysis and metastasis |
| 07/03/2002 | EP0758221B1 Hair-treatment agents |
| 07/03/2002 | EP0723777B1 Tablet containing enteric granules |
| 07/03/2002 | EP0698393B1 3-l-MENTHOXY-PROPANE-1, 2-DIOL AS SOLUBILIZING AGENT AND EXTERNAL PREPARATION CONTAINING THE SAME |
| 07/03/2002 | EP0667148B1 Peroral pharmaceutical preparation releasable in lower digestive tract |
| 07/03/2002 | EP0661045B1 Sustained-release hydrogel preparation |
| 07/03/2002 | EP0637248B1 Pharmaceutical composition containing cyclosporin derivative |
| 07/03/2002 | CN2497789Y Skin penetrating preparation for treating male sextual disorder |
| 07/03/2002 | CN1357038A Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| 07/03/2002 | CN1357037A Method for preservation of biological-active material |
| 07/03/2002 | CN1357023A Controlled release polyacrylic acid granules and process for preparing same |
| 07/03/2002 | CN1356975A Amorphous nitric esters and their pharmaceutical compsns. |
| 07/03/2002 | CN1356910A Model membrane systems |
| 07/03/2002 | CN1356908A Pharmaceutical formulation comprising low molecular weight thrombin inhibitor and its prodrug |
| 07/03/2002 | CN1356907A Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/03/2002 | CN1356906A Therapeutic methods and compsns. for treatment of in paired interpersonal and behavioral disorders |
| 07/03/2002 | CN1356901A Pharmaceutical compsn. and process for its prepn. |
| 07/03/2002 | CN1356896A Anesthetic compsn. for intravenous injection comprising propofol |
| 07/03/2002 | CN1356895A Microreservoir system on basis of polysiloxanes and ambiphilic solvents |
| 07/03/2002 | CN1356894A Transdermal therapeutic system (TTS) contg. tolterodine |
| 07/03/2002 | CN1356893A New formulation |
| 07/03/2002 | CN1356892A Use of biodegradable microspheres for delivery of anticancer for treatment of glioblastoma |
| 07/03/2002 | CN1356883A Vacuum assisted closure system with provision for introduction of agent |
| 07/03/2002 | CN1356876A Compsns. containing creatine in suspension |
| 07/03/2002 | CN1356397A Process for preparing powder containing maltose alcohol crystal grains |
| 07/03/2002 | CN1356143A Emulsion-type lubricant and its application in medical rubber product |
| 07/03/2002 | CN1356116A Buccal cordyceps lozenge |
| 07/03/2002 | CN1356107A Freezing-dried injection powder 'Katisu' and its preparing process |
| 07/03/2002 | CN1356102A Taste Masked medicine particles |
| 07/03/2002 | CN1086955C Ointment for treating burn and scald and its preparing process |
| 07/03/2002 | CN1086951C Instant powder for common cold |
| 07/03/2002 | CN1086950C Medicine for treating soft tissue injury |
| 07/03/2002 | CN1086946C Thrombus dissolving capsule |
| 07/03/2002 | CN1086941C Hard gelatin capsules resistant to denaturation and prodn. thereof |
| 07/03/2002 | CN1086940C Dinucleotides useful for treating lung disease |
| 07/03/2002 | CN1086917C Chewing gum compsn. and prodn. thereof |
| 07/02/2002 | US6415167 Fiber optic probe placement guide |
| 07/02/2002 | US6414264 Laser beam cutting method for cutting laminates for applying to the skin |
| 07/02/2002 | US6414136 Adsorption of fluorescent dye-labeled molecules not incorporated in polymer onto hydrophobic material after passing through hydrophilic matrix |
| 07/02/2002 | US6414050 Biofunctional polymers prepared in supercritical fluid |
| 07/02/2002 | US6414037 Pharmaceutical formulations of resveratrol and methods of use thereof |
| 07/02/2002 | US6414035 Candida infections |
| 07/02/2002 | US6414033 Determination ph; buffer solution |
| 07/02/2002 | US6414032 Anti-infective compositions for treating disordered tissue such as cold sores |
| 07/02/2002 | US6414028 Mixture with skin penetration intensifier, polysaccharide gum and buffer |
| 07/02/2002 | US6414027 Methods and compositions for treating male erectile dysfunction |
| 07/02/2002 | US6414021 Vision defects |
| 07/02/2002 | US6413988 Prucalopride oral solution |
| 07/02/2002 | US6413950 Topical application; skin disorders |
| 07/02/2002 | US6413942 Methods of delivering a physiologically active polypeptide to a mammal |
| 07/02/2002 | US6413941 Polymer composition for delivering a nucleic acid or derivative thereof |
| 07/02/2002 | US6413552 Topically applied creatine containing composition |
| 07/02/2002 | US6413550 Proteinoid carriers and methods for preparation and use thereof |
| 07/02/2002 | US6413549 Freeze drying |
| 07/02/2002 | US6413548 Particulate encapsulation of liquid beads |
| 07/02/2002 | US6413547 Thermotropic; antibiotics; antiinflammatory agents; antihistamines |
| 07/02/2002 | US6413546 Tablets incorporating isoflavone plant extracts and methods of manufacturing them |
| 07/02/2002 | US6413544 Sandwich liposome comprises biologically active agents internalized between two bilomellar liposomes; 1,2-bis(oleoyloxy)-3-(trimethylammonio)-propane chloride, cholesterol or cholesterol derivative |
| 07/02/2002 | US6413543 Phosphatidyl oligoglycerols |
| 07/02/2002 | US6413541 Dissolving a saccharide, mixing the solution with excipient; gradulation, drying, tabletting; aging |
| 07/02/2002 | US6413540 For eyes |
| 07/02/2002 | US6413539 Block polymer |
| 07/02/2002 | US6413536 High viscosity liquid controlled delivery system and medical or surgical device |
| 07/02/2002 | US6413533 Administering antiestrogen |
| 07/02/2002 | US6413527 Nanoemulsion based on alkyl ether citrates and its uses in the cosmetics, dermatological, pharmacological and/or ophthalmological fields |
| 07/02/2002 | US6413507 Modified polyether |
| 07/02/2002 | US6413499 Absorption; controlling concentration to nasal cavity |
| 07/02/2002 | US6413497 Inhalation |
| 07/02/2002 | US6413496 Pharmaceutical compositions and devices for their administration |
| 07/02/2002 | US6413494 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 07/02/2002 | US6413463 Process for producing hard capsule |
| 07/02/2002 | CA2333528C A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer |
| 07/02/2002 | CA2255955C Cosmetic compositions |
| 07/02/2002 | CA2217339C Non-ionic and cationic amphiphilic lipid-based nanoemulsion and its uses |